After Low Dose Naltrexone helped Linda Elsegood with her progressive MS, she took it on as a personal mission to bring more information to the general public about this amazing drug. She founded the LDN Research Trust, and is discussing her new book “The LDN Book: How a Little Known Generic Drug—Low Dose Naltrexone—could revolutionize treatment for Autoimmune diseases, Cancer, Autism, Depression and More” in this interview.